FFO
KRRO icon

Fortitude Family Office’s Korro Bio KRRO Stock Holding History

Fortitude Family Office’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39
Closed -$441 – 2329
2026
Q1 		$441 Buy
+39
New +$429 ﹤0.01% 1773

Other funds holding KRRO

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Fortitude Family Office's KRRO Position: Q2 2026 in Review

Fortitude Family Office sold out of Korro Bio (KRRO) in Q2 2026, closing a stake of 39 shares — an estimated $441 sold.

Fortitude Family Office first reported a position in KRRO in Q1 2026 and held it in 1 quarter. The position peaked at $441 in Q1 2026. 11 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Fortitude Family Office reported no remaining Korro Bio position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 39 Korro Bio shares in Q2 2026, an estimated $441.
  • Fortitude Family Office first reported a position in Korro Bio in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Korro Bio position peaked at $441 in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.